T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.
about
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyNasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer diseaseT cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions.Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune diseaseGlatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.ROCKs as immunomodulators of strokeGlatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of actionHow and why do T cells and their derived cytokines affect the injured and healthy brain?Multifaceted interactions between adaptive immunity and the central nervous system.Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situBCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Impact of acute inflammation on spinal motoneuron synaptic plasticity following ventral root avulsion.Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigensThe potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis miceRetinal stem cells transplantation combined with copolymer-1 immunization reduces interferon-gamma levels in an experimental model of glaucoma.Multiple sclerosis: overview of disease-modifying agentsGlatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell deathVaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucomaMultiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's diseaseEffects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.Glatiramer acetate for the treatment of multiple sclerosis.On the horizon: possible neuroprotective role for glatiramer acetate.T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironmentGlatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Solving the lost in translation problem: improving the effectiveness of translational research.Glatiramer acetate therapy for multiple sclerosis: a review.Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma.Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisMechanism of action of glatiramer acetate in treatment of multiple sclerosis.Boosting controlled autoimmunity: a new therapeutic target for CNS disorders.Neuroprotection in glaucoma: drug-based approaches.Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis.Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis.
P2860
Q21034132-0BCC0492-F95B-41DC-A0B3-28AB9D56C5D0Q24534813-A452D789-F93F-4DD8-ADA7-57340956FA27Q24562400-B10898DB-3BC3-4ED3-9E15-92400E34CD8DQ24671661-DA806A31-E4EB-48A8-92BF-0FD2DD991C21Q24676445-9B978593-1B5E-47C8-A9C8-64E4C4CC82DAQ24681228-DA2B61AD-465B-4AF3-AFAB-8C6B05DD284CQ26853214-D3FC81E2-73F2-4825-993E-90A9A3A62702Q28308287-463A0E05-DB2C-4C18-BED1-C7F1CA6BBD38Q30252510-1E6A42CE-D4FF-42BC-9B4D-3285D096108BQ30276094-7AD67C02-5E4D-4582-8A9D-C4606707022FQ30412083-93B6A9DF-7EB4-45BB-B11A-4A626B04E371Q30426525-A67A5B46-F2D1-4607-B199-25F385A5DACAQ33354106-2059D5E3-361D-4B9C-862A-CA330D30F215Q33715636-99736D1A-FB86-4679-82E0-C796C6F4DB19Q33815568-4552B7C8-106B-4162-87F6-838AC6F3F569Q33868983-7DDEA036-F179-4A6D-8BE2-FAFB261502D2Q33953007-BA7E2F96-9652-44B6-9970-4C4DF2293F32Q33972545-F8ED672C-6936-4AB3-9768-97994F6A84A7Q33988381-CB0A283D-0A7D-4C92-A4CD-36CBF2D254B8Q34245104-AFE54D39-CFA9-42BB-94C9-7E06C061CF2DQ34254620-5DC38717-CB9C-44B4-AF31-19B9AAE919BAQ34342662-578D7CAC-675B-40ED-B0F0-E2D2964FB48AQ34358322-0AB2F292-1C7F-4F0F-9F53-1EFEE8B3C3F2Q34734517-EB9E19C8-F0FF-4E7A-B473-842EB47A8C06Q34956279-EDD5C000-05CE-4527-8802-038ED18CCF3FQ35320917-7B15A891-005F-47E5-A3C9-A7A4C527F420Q35607258-D79BCD1D-65CB-451D-926A-148582E83E63Q35753417-CFA0112F-239B-46A6-9AC1-219AC4BC44F2Q35818185-BE2D74F1-735E-4D03-9CE9-7FC52197DD8EQ36099316-3779A335-BD6E-4328-A17C-B08E74A8D960Q36432500-067C55F8-B303-4DA2-85BD-ABE59FCE915CQ36487221-1BD4CB22-9610-4F41-9101-2D1372105624Q36662903-AB4DFE5C-4793-4D03-AAE3-364F8CEBA67AQ36833382-6D20B40B-7C75-468C-9C56-8CA4A6E17B09Q36837427-6685C3BB-626E-4929-A850-63AE33AEDB53Q36963184-C5AD2016-0AD3-4D9C-ABF3-46E0DC763C45Q37154818-28E3CE73-D618-464A-9220-9C4894478C13Q37180770-5F88F255-D21E-429D-AEE1-04BC735CAE9CQ37295387-77302D4B-C7FD-4169-A4F7-00A52317A3F9Q37325159-8D70D149-4696-4149-B22C-32767C16839C
P2860
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@ast
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@en
type
label
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@ast
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@en
prefLabel
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@ast
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@en
P2093
P2860
P356
P1476
T cell immunity to copolymer 1 ...... herapy for optic neuropathies.
@en
P2093
M Schwartz
P2860
P304
P356
10.1073/PNAS.97.13.7446
P407
P577
2000-06-01T00:00:00Z